T. Rowe Price Associates
ZBH icon

T. Rowe Price Associates’s Zimmer Biomet ZBH Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.35B Buy
14,796,604
+339,742
+2% +$31M 0.15% 131
2025
Q1
$1.64B Sell
14,456,862
-303,582
-2% -$34.4M 0.2% 96
2024
Q4
$1.56B Buy
14,760,444
+176,337
+1% +$18.6M 0.18% 107
2024
Q3
$1.57B Buy
14,584,107
+2,078,774
+17% +$224M 0.18% 107
2024
Q2
$1.36B Buy
12,505,333
+1,862,532
+18% +$202M 0.16% 123
2024
Q1
$1.4B Buy
10,642,801
+1,215,935
+13% +$160M 0.17% 126
2023
Q4
$1.15B Buy
9,426,866
+1,458,359
+18% +$177M 0.15% 141
2023
Q3
$894M Sell
7,968,507
-1,254,625
-14% -$141M 0.13% 163
2023
Q2
$1.34B Sell
9,223,132
-1,208,907
-12% -$176M 0.19% 107
2023
Q1
$1.35B Sell
10,432,039
-768,070
-7% -$99.2M 0.2% 106
2022
Q4
$1.43B Buy
11,200,109
+650,886
+6% +$83M 0.23% 94
2022
Q3
$1.1B Buy
10,549,223
+1,619,881
+18% +$169M 0.18% 113
2022
Q2
$938M Buy
8,929,342
+1,062,625
+14% +$112M 0.12% 190
2022
Q1
$1.01B Sell
7,866,717
-317,227
-4% -$40.6M 0.1% 205
2021
Q4
$1.04B Buy
8,183,944
+412,503
+5% +$52.4M 0.09% 215
2021
Q3
$1.14B Buy
7,771,441
+1,715,786
+28% +$251M 0.11% 195
2021
Q2
$974M Buy
6,055,655
+928,419
+18% +$149M 0.09% 233
2021
Q1
$821M Sell
5,127,236
-656,380
-11% -$105M 0.08% 252
2020
Q4
$891M Sell
5,783,616
-740,398
-11% -$114M 0.09% 234
2020
Q3
$888M Buy
6,524,014
+279,783
+4% +$38.1M 0.1% 208
2020
Q2
$745M Sell
6,244,231
-288,263
-4% -$34.4M 0.09% 222
2020
Q1
$660M Buy
6,532,494
+386,959
+6% +$39.1M 0.1% 207
2019
Q4
$920M Sell
6,145,535
-108,203
-2% -$16.2M 0.12% 188
2019
Q3
$858M Buy
6,253,738
+199,534
+3% +$27.4M 0.12% 189
2019
Q2
$713M Buy
6,054,204
+177,006
+3% +$20.8M 0.1% 215
2019
Q1
$751M Buy
5,877,198
+619,098
+12% +$79.1M 0.11% 198
2018
Q4
$545M Buy
5,258,100
+2,367,529
+82% +$246M 0.09% 220
2018
Q3
$380M Buy
2,890,571
+508,461
+21% +$66.8M 0.06% 332
2018
Q2
$265M Buy
2,382,110
+616,435
+35% +$68.7M 0.04% 399
2018
Q1
$193M Buy
1,765,675
+109,622
+7% +$12M 0.03% 470
2017
Q4
$200M Buy
1,656,053
+37,497
+2% +$4.52M 0.03% 461
2017
Q3
$190M Buy
1,618,556
+185,113
+13% +$21.7M 0.03% 458
2017
Q2
$184M Sell
1,433,443
-6,328
-0.4% -$813K 0.03% 458
2017
Q1
$176M Buy
1,439,771
+85,269
+6% +$10.4M 0.03% 456
2016
Q4
$140M Buy
1,354,502
+917,922
+210% +$94.7M 0.03% 501
2016
Q3
$56.8M Buy
436,580
+80,880
+23% +$10.5M 0.01% 768
2016
Q2
$42.8M Buy
355,700
+27,344
+8% +$3.29M 0.01% 845
2016
Q1
$35M Buy
328,356
+22,200
+7% +$2.37M 0.01% 902
2015
Q4
$31.4M Sell
306,156
-20,750
-6% -$2.13M 0.01% 937
2015
Q3
$30.7M Sell
326,906
-2,690
-0.8% -$253K 0.01% 950
2015
Q2
$36M Buy
329,596
+15,880
+5% +$1.73M 0.01% 948
2015
Q1
$36.9M Buy
313,716
+19,400
+7% +$2.28M 0.01% 931
2014
Q4
$33.4M Buy
294,316
+9,690
+3% +$1.1M 0.01% 978
2014
Q3
$28.6M Buy
284,626
+1,200
+0.4% +$121K 0.01% 1020
2014
Q2
$29.4M Buy
283,426
+14,400
+5% +$1.5M 0.01% 1018
2014
Q1
$25.4M Sell
269,026
-189,200
-41% -$17.9M 0.01% 1048
2013
Q4
$42.7M Sell
458,226
-258,640
-36% -$24.1M 0.01% 888
2013
Q3
$58.9M Sell
716,866
-62,046
-8% -$5.1M 0.01% 756
2013
Q2
$58.4M Buy
+778,912
New +$58.4M 0.02% 732